We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Consent Decree Expanded to Include All of Cardinal’s Infusion Pumps
Consent Decree Expanded to Include All of Cardinal’s Infusion Pumps
March 5, 2009
The FDA and Cardinal Health have agreed to expand the company’s consent decree related to the manufacture of the Alaris SE line of infusion pumps to include all infusion pumps marketed by the company’s Cardinal Health 303 subsidiary.